How well do health systems monitor HIV-associated comorbidities? HIV Outcomes at HIV Drug Therapy Glasgow 2018
News
25 October 2018

How well do health systems monitor HIV-associated comorbidities? HIV Outcomes at HIV Drug Therapy Glasgow 2018

Steering group co-chair Professor Jane Anderson (Consultant Physician, Homerton University Hospital, London) will present findings from HIV Outcomes' assessment of how effectively health systems are monitoring HIV-associated comorbidities at this year's HIV Drug Therapy conference in Glasgow on 28-31 October 2018.

While HIV has become a chronic condition, evidence suggests that there are a growing number of people living with HIV suffering from non-AIDS-defining comorbidities. Using current global and European frameworks, the HIV Outcomes abstract assesses whether existing monitoring frameworks sufficiently enable European countries to observe and understand the comorbidities that impact on the health and well-being of people living with HIV.

The abstract is taken from research work being undertaken by the HIV Outcomes study group.

More updates All

11 October 2018
Following the launch of multi-stakeholder recommendations in 2017, HIV Outcomes is calling for good practice examples from across the WHO Europe region on the long-term health, well-being and chronic care of ...
More
Press Releases
29 November 2017
Brussels, 29 November 2017: Experts unveiled a set of recommendations on Wednesday to address health problems facing people living with HIV. Treatments are helping people with HIV live long lives, but they face higher risk than others of serious illnesses – from cancer ...
More
News
26 July 2017
At the meeting of the HIV Outcomes initiative on 1 June, Mario Cascio (EATG member and Steering Committee member of ‘Ageing with HIV’), gave a personal account of what it means to age with HIV. Significantly, he noted that the greatest ...
More
Filters
Initiative Partners
  • Aids Action Europe
  • AFEW International
  • East Europe and Central Asia Union of PLWH
  • European AIDS Treatment Group
  • Gilead
  • ViiV Healthcare
This initiative is enabled by sponsorship provided by Gilead Sciences and ViiV Healthcare.